TET3 inhibits TGF-β1-induced epithelial-mesenchymal transition by demethylating miR-30d precursor gene in ovarian cancer cells

Table 3 Clinicopathological correlation of TET3 to ovarian cancer

			Immunohistochemical composite scores
Clinicopathological parameters of ovarian cancer	Overall Positivity^a	P value	Mean	SD	P value
Age^b
< 50 (n = 25)	17 (68 %)	0.3793	0.65	0.77	0.9822
≥ 50 (n = 39)	31 (78.5 %)		0.66	0.62
NA (n = 4)
Grade^c
G1 (n = 7)	7 (100 %)	0.024*	0.73	0.50	0.2409
G2 (n = 26)	23 (88.5 %)		0.93	0.76
G3 (n = 29)	18 (62.1 %)		0.59	0.76

^aPercentage of cases with more than 5 % positive cells. ^bFisher’s Exact Test (two-tailed). ^ct-test or one-way ANOVA (two-tailed). NA non-available
* P < 0.05

ISSN: 1756-9966